173 related articles for article (PubMed ID: 17696418)
21. Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors: investigating the relationships involving stereochemistry, hydrogen bonding, and biological activity.
Peterson KE; Cinelli MA; Morrell AE; Mehta A; Dexheimer TS; Agama K; Antony S; Pommier Y; Cushman M
J Med Chem; 2011 Jul; 54(14):4937-53. PubMed ID: 21710981
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.
My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ
Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties of novel indeno[2,1-c]quinolin-7-one and indeno[1,2-c]isoquinolin-5,11-dione derivatives.
Ryckebusch A; Garcin D; Lansiaux A; Goossens JF; Baldeyrou B; Houssin R; Bailly C; Hénichart JP
J Med Chem; 2008 Jun; 51(12):3617-29. PubMed ID: 18507368
[TBL] [Abstract][Full Text] [Related]
24. Identification, synthesis, and biological evaluation of metabolites of the experimental cancer treatment drugs indotecan (LMP400) and indimitecan (LMP776) and investigation of isomerically hydroxylated indenoisoquinoline analogues as topoisomerase I poisons.
Cinelli MA; Reddy PV; Lv PC; Liang JH; Chen L; Agama K; Pommier Y; van Breemen RB; Cushman M
J Med Chem; 2012 Dec; 55(24):10844-62. PubMed ID: 23215354
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.
Strumberg D; Pommier Y; Paull K; Jayaraman M; Nagafuji P; Cushman M
J Med Chem; 1999 Feb; 42(3):446-57. PubMed ID: 9986716
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, cytotoxicity and topoisomerase inhibition properties of multifarious aminoalkylated indeno[1,2-c]isoquinolin-5,11-diones.
Ahn G; Schifano-Faux N; Goossens JF; Baldeyrou B; Couture A; Grandclaudon P; Lansiaux A; Ryckebusch A
Bioorg Med Chem Lett; 2011 Apr; 21(8):2259-63. PubMed ID: 21439821
[TBL] [Abstract][Full Text] [Related]
27. 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.
Kiselev E; DeGuire S; Morrell A; Agama K; Dexheimer TS; Pommier Y; Cushman M
J Med Chem; 2011 Sep; 54(17):6106-16. PubMed ID: 21823606
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.
Nguyen TX; Abdelmalak M; Marchand C; Agama K; Pommier Y; Cushman M
J Med Chem; 2015 Apr; 58(7):3188-208. PubMed ID: 25811317
[TBL] [Abstract][Full Text] [Related]
29. On the binding of indeno[1,2-c]isoquinolines in the DNA-topoisomerase I cleavage complex.
Xiao X; Antony S; Pommier Y; Cushman M
J Med Chem; 2005 May; 48(9):3231-8. PubMed ID: 15857129
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors.
Nguyen TX; Morrell A; Conda-Sheridan M; Marchand C; Agama K; Bermingham A; Bermingam A; Stephen AG; Chergui A; Naumova A; Fisher R; O'Keefe BR; Pommier Y; Cushman M
J Med Chem; 2012 May; 55(9):4457-78. PubMed ID: 22536944
[TBL] [Abstract][Full Text] [Related]
31. Design and Synthesis of Chlorinated and Fluorinated 7-Azaindenoisoquinolines as Potent Cytotoxic Anticancer Agents That Inhibit Topoisomerase I.
Elsayed MSA; Su Y; Wang P; Sethi T; Agama K; Ravji A; Redon CE; Kiselev E; Horzmann KA; Freeman JL; Pommier Y; Cushman M
J Med Chem; 2017 Jul; 60(13):5364-5376. PubMed ID: 28657311
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of indenoisoquinoline topoisomerase I inhibitors using a hollow fiber assay.
Morrell A; Jayaraman M; Nagarajan M; Fox BM; Meckley MR; Ioanoviciu A; Pommier Y; Antony S; Hollingshead M; Cushman M
Bioorg Med Chem Lett; 2006 Aug; 16(16):4395-9. PubMed ID: 16750365
[TBL] [Abstract][Full Text] [Related]
33. Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex.
Staker BL; Feese MD; Cushman M; Pommier Y; Zembower D; Stewart L; Burgin AB
J Med Chem; 2005 Apr; 48(7):2336-45. PubMed ID: 15801827
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model.
Jayaraman M; Fox BM; Hollingshead M; Kohlhagen G; Pommier Y; Cushman M
J Med Chem; 2002 Jan; 45(1):242-9. PubMed ID: 11754595
[TBL] [Abstract][Full Text] [Related]
35. Indenoisoquinoline Topoisomerase Inhibitors Strongly Bind and Stabilize the
Wang KB; Elsayed MSA; Wu G; Deng N; Cushman M; Yang D
J Am Chem Soc; 2019 Jul; 141(28):11059-11070. PubMed ID: 31283877
[No Abstract] [Full Text] [Related]
36. Synthesis of benzo[3,4]azepino[1,2-b]isoquinolin-9-ones from 3-arylisoquinolines via ring closing metathesis and evaluation of topoisomerase I inhibitory activity, cytotoxicity and docking study.
Van HT; Khadka DB; Yang SH; Le TN; Cho SH; Zhao C; Lee IS; Kwon Y; Lee KT; Kim YC; Cho WJ
Bioorg Med Chem; 2011 Sep; 19(18):5311-20. PubMed ID: 21873069
[TBL] [Abstract][Full Text] [Related]
37. Molecular determinants of topoisomerase I poisoning by lamellarins: comparison with camptothecin and structure-activity relationships.
Marco E; Laine W; Tardy C; Lansiaux A; Iwao M; Ishibashi F; Bailly C; Gago F
J Med Chem; 2005 Jun; 48(11):3796-807. PubMed ID: 15916431
[TBL] [Abstract][Full Text] [Related]
38. The structure-activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode.
Cinelli MA; Morrell AE; Dexheimer TS; Agama K; Agrawal S; Pommier Y; Cushman M
Bioorg Med Chem; 2010 Aug; 18(15):5535-52. PubMed ID: 20630766
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological evaluation of 3-substituted indenoisoquinoline derivatives as topoisomerase I inhibitors.
Zhao Q; Xu X; Xie Z; Liu X; You Q; Guo Q; Zhong Y; Li Z
Bioorg Med Chem Lett; 2016 Feb; 26(3):1068-1072. PubMed ID: 26725027
[TBL] [Abstract][Full Text] [Related]
40. Investigation of the Structure-Activity Relationships of Aza-A-Ring Indenoisoquinoline Topoisomerase I Poisons.
Beck DE; Reddy PV; Lv W; Abdelmalak M; Tender GS; Lopez S; Agama K; Marchand C; Pommier Y; Cushman M
J Med Chem; 2016 Apr; 59(8):3840-53. PubMed ID: 27070999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]